Women’s health Archives - Page 2 of 6

A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications

Girija Narendrakumar Wagh, KM Kundavi Shankar, Sumitra Bachani

Article Type

Review

Published

13 Oct 2021

This narrative review examines the available evidence for oral natural micronized progesterone (NMP) and sustained-release formulation of NMP (NMP-SR) in several obstetric indications of interest.

Less common bacterial, fungal and viral infections: review of management in the pregnant patient

Alyssa P Gould, Hana R Winders, Kayla R Stover, P Brandon Bookstaver, Brooke Griffin, Christopher M Bland, Lea S Eiland, Milena Murray

Article Type

Review

Published

22 Sep 2021

This review is a comprehensive summary of treatment options for pregnant patients with less common bacterial, fungal, and viral infections.

A non-pharmacological approach to the treatment of urinary tract infections: case reports with Utipro® Plus

Tommaso Cai, Cristian Konstantinidis, Sam Ward

Article Type

Review

Published

24 May 2021

Using illustrative case reports, this review documents outcomes in three women with recurrent urinary tract infections who were treated with Utipro® Plus in clinical practice.

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference

John C Stevenson MB BS, FRCP, FESC, MFSEM, Serge Rozenberg MD, PhD, Silvia Maffei MD, Christian Egarter Prof Dr Med, Petra Stute Prof Dr Med, Thomas Römer Prof Dr Med

Article Type

Review

Published

02 Dec 2020

This narrative review examines the role of progestogens in MHT, with the aim of providing practical recommendations for prescribing physicians.

Potential risk of drug–drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV

Milena M Murray PharmD, MSc, Ashley Jensen PharmD, Thomas Cieslik PharmD Candidate, Susan E Cohn MD, MPH

Article Type

Original Research

Published

05 Aug 2020

The objectives of this study were to assess antiretroviral therapy and hormonal contraceptive use among women living with HIV and quantify the frequency of potential drug–drug interactions between antiretroviral therapy and hormonal contraceptives.